Stockscreener 앱 받기
0.429
0.07%
-0.0038
전일 마감가:
$0.4328
열려 있는:
$0.445
하루 거래량:
25,777
Relative Volume:
0.08
시가총액:
$7.93M
수익:
$174.80K
순이익/손실:
$-8.85M
주가수익비율:
-0.6229
EPS:
-0.6887
순현금흐름:
$-4.37M
1주 성능:
-2.04%
1개월 성능:
-9.63%
6개월 성능:
-50.14%
1년 성능:
-79.98%
1일 변동 폭
$0.4251
$0.445
1주일 범위
$0.4251
$0.4552
52주 변동 폭
$0.3679
$2.57
Nexalin Technology Inc Stock (NXL) Company Profile
명칭
Nexalin Technology Inc
전화
(832) 260-0222
주소
1776 YORKTOWN, HOUSTON
Compare NXL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.4251 | 8.07M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
110.13 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.37 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.00 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.85 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.48 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
Nexalin Technology Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Short Squeeze: What is Nexalin Technology Inc Equity Warrants 5 year growth outlookWeekly Trade Summary & Fast Moving Market Watchlists - baoquankhu1.vn
Short Squeeze: Will Nexalin Technology Inc. stock deliver shareholder valuePortfolio Risk Report & Precise Swing Trade Entry Alerts - Naître et grandir
Exit Recap: Can Nexalin Technology Inc. deliver consistent dividends2025 Market WrapUp & Long Hold Capital Preservation Tips - baoquankhu1.vn
Ideas Watch: Does Nexalin Technology Inc have consistent dividend growthQuarterly Investment Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Market Catalysts: Whats next for Nexalin Technology Inc Equity Warrant stock2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
NXL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Hedge Fund Bets: What are analysts price targets for Nexalin Technology Inc Equity Warrant2025 Market WrapUp & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Nexalin Advances Pivotal HALO Clarity Trial for Insomnia - The Globe and Mail
Nexalin Announces 150-Patient Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission - TradingView
Nexalin (Nasdaq: NXL) advances pivotal HALO Clarity insomnia trial toward FDA de novo bid - Stock Titan
Nasdaq Moves: Can Nexalin Technology Inc Equity Warrant continue delivering strong returns2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Nexalin Launches Pivotal HALO Clarity Trial To Support Planned FDA Submission For Insomnia - Nasdaq
Nexalin announces pivotal Halo(TM) Clarity trial - marketscreener.com
Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market - The Manila Times
Drug-free insomnia device trial targets 30 million adults - Stock Titan
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Bitget
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders - Bitget
Nexalin Technology, Inc. Applauds Bipartisan Congressional Support for Deep Brain Neurostimulation Research and Expanding Access for Veterans - Quiver Quantitative
Congress boosts brain stimulation research for veterans, with Nexalin involved - Stock Titan
Can Nexalin Technology Inc. Equity Warrant be recession proofMarket Sentiment Summary & Reliable Momentum Entry Alerts - mfd.ru
Will Nexalin Technology Inc. Equity Warrant outperform during market ralliesPortfolio Value Summary & Weekly High Conviction Ideas - mfd.ru
Is Nexalin Technology Inc. stock forming a cup and handleShort Setup & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Aug Intraday: Will Nexalin Technology Inc Equity Warrant outperform during market rallies2025 Buyback Activity & Consistent Income Trade Ideas - baoquankhu1.vn
Breakout Move: What are CCTGs earnings expectations2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
NXL Should I Buy - Intellectia AI
A | Can ONFO stock beat analyst upgradesJuly 2025 Highlights & Target Return Focused Picks - mfd.ru
What’s Nexalin Technology Inc. Equity Warrant’s historical returnEarnings Recap Report & Weekly High Potential Alerts - mfd.ru
Will Nexalin Technology Inc. Equity Warrant stock benefit from sector rotation2025 AllTime Highs & Verified Stock Trade Ideas - mfd.ru
Market Leaders: Will Nexalin Technology Inc benefit from geopolitical trendsInflation Watch & Safe Capital Growth Stock Tips - baoquankhu1.vn
NXL Technical Analysis & Stock Price Forecast - Intellectia AI
Nexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Aug Gainers: Is RSVR a turnaround storyJuly 2025 Macro Moves & Safe Capital Growth Plans - baoquankhu1.vn
Nexalin Technology receives Nasdaq bid price deficiency notice - MSN
Risk Hedge: Can Nexalin Technology Inc. Equity Warrant outperform in the next rallyJuly 2025 Reactions & Community Consensus Trade Signals - mfd.ru
SEC Filings | Track, Search, and Analyze Public Company Disclosures - SECFilings.com
Decliners Report: Can Nexalin Technology Inc deliver consistent dividendsWeekly Trend Recap & Daily Volume Surge Signals - baoquankhu1.vn
Market Pulse: Will Nexalin Technology Inc benefit from geopolitical trendsQuarterly Growth Report & Technical Pattern Alert System - baoquankhu1.vn
Nexalin Launches NeuroCare, An AI Virtual Clinic for Brain Health Disorders - AIM Media House
Aug Drivers: Does Nexalin Technology Inc Equity Warrant have strong fundamentalsStop Loss & Verified High Yield Trade Plans - baoquankhu1.vn
Nexalin Technology stock rises after launching AI-powered virtual clinic By Investing.com - Investing.com Australia
Nexalin Technology stock rises after launching AI-powered virtual clinic - Investing.com
Nexalin Technology, Inc. Launches NeuroCare® Virtual Clinic Platform in Collaboration with UC San Diego to Enhance Brain Health Treatment Access and Monitoring - Quiver Quantitative
Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care - ChartMill
EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings - Benzinga
Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic - GlobeNewswire
Nexalin Expands Peer-Reviewed Evidence For DIFS Non-Invasive Brain Stimulation - Nasdaq
Nexalin reports brain imaging studies validate its neurostimulation tech By Investing.com - Investing.com Nigeria
Nexalin reports brain imaging studies validate its neurostimulation tech - Investing.com
Nexalin Technology, Inc. Showcases Validation of DIFS™ Neurostimulation Technology Through Extensive Clinical Research - Quiver Quantitative
Nexalin Highlights its Expanding Body of Peer-Reviewed - GlobeNewswire
Nexalin Technology Inc (NXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.61%
1.39%
자본화:
|
볼륨(24시간):